$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

$ntip Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000107261324000458 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$100.0K		$537.0K
YoY Change	-64.66%
Cost Of Revenue	$28.00K	$0.00	$151.0K
YoY Change	-65.43%	-100.0%
Gross Profit	$72.00K	$0.00	$386.0K
YoY Change	-64.36%	-100.0%
Gross Profit Margin	72.0%		71.88%
Selling, General & Admin	$666.0K	$888.0K	$1.079M
YoY Change	-0.45%	-17.7%	31.27%
% of Gross Profit	925.0%		279.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$30.00K	$30.00K	$83.00K
YoY Change	-63.41%	-63.86%	10.67%
% of Gross Profit	41.67%		21.5%
Operating Expenses	$724.0K	$918.0K	$1.313M
YoY Change	-12.98%	-30.08%	46.38%
Operating Profit	-$624.0K	-$918.0K	-$776.0K
YoY Change	13.66%	18.3%	-13.49%
Interest Expense	$506.0K	$479.0K	$674.0K
YoY Change	36.76%	-28.93%	-255.3%
% of Operating Profit
Other Income/Expense, Net		$479.0K	$674.0K
YoY Change		-28.93%	-255.3%
Pretax Income	-$118.0K	-$439.0K	-$102.0K
YoY Change	-34.08%	330.39%	-92.34%
Income Tax	-$137.0K	-$147.0K	-$153.0K
% Of Pretax Income
Net Earnings	-$658.0K	-$920.0K	-$623.0K
YoY Change	38.24%	47.67%	-52.52%
Net Earnings / Revenue	-658.0%		-116.01%
Basic Earnings Per Share	-$0.03	-$0.04	-$0.03
Diluted Earnings Per Share	-$0.03	-$0.04	-$0.03
COMMON SHARES
Basic Shares Outstanding	23.41M shares	23.51M shares	23.82M shares
Diluted Shares Outstanding	23.30M shares	23.54M shares	23.87M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$42.60M	$43.39M	$46.84M
YoY Change	-8.13%	-7.35%	-17.15%
Cash & Equivalents	$19.94M	$18.11M	$9.919M
Short-Term Investments	$22.66M	$25.29M	$36.92M
Other Short-Term Assets	$182.0K	$218.0K	$119.0K
YoY Change	106.82%	83.19%	7.21%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$42.78M	$43.61M	$47.14M
YoY Change	-8.26%	-7.47%	-16.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$59.00K	$75.00K	$145.0K
YoY Change	-54.26%	-48.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.944M	$4.621M	$6.578M
YoY Change	-36.25%	-29.75%	104.41%
Other Assets	$13.00K	$13.00K	$13.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$5.282M	$6.005M	$8.245M
YoY Change	-31.9%	-27.17%	62.82%
TOTAL ASSETS
Total Short-Term Assets	$42.78M	$43.61M	$47.14M
Total Long-Term Assets	$5.282M	$6.005M	$8.245M
Total Assets	$48.06M	$49.62M	$55.38M
YoY Change	-11.63%	-10.41%	-10.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$206.0K	$306.0K	$601.0K
YoY Change	-45.07%	-49.08%	22.65%
Accrued Expenses	$206.0K	$239.0K	$517.0K
YoY Change	-21.07%	-53.77%	-9.14%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$412.0K	$545.0K	$1.233M
YoY Change	-45.14%	-55.8%	-69.26%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$24.00K	$77.00K
YoY Change		-68.83%
Total Long-Term Liabilities	$0.00	$24.00K	$77.00K
YoY Change	-100.0%	-68.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$412.0K	$545.0K	$1.233M
Total Long-Term Liabilities	$0.00	$24.00K	$77.00K
Total Liabilities	$890.0K	$1.184M	$2.318M
YoY Change	-48.41%	-48.92%	-43.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.71M	-$19.36M	-$14.26M
YoY Change	40.3%	35.76%
Common Stock	$232.0K	$235.0K	$239.0K
YoY Change	-2.52%	-1.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$47.17M	$48.43M	$53.06M
YoY Change
Total Liabilities & Shareholders Equity	$48.06M	$49.62M	$55.38M
YoY Change	-11.63%	-10.41%	-10.26%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$658.0K	-$920.0K	-$623.0K
YoY Change	38.24%	47.67%	-52.52%
Depreciation, Depletion And Amortization	$30.00K	$30.00K	$83.00K
YoY Change	-63.41%	-63.86%	10.67%
Cash From Operating Activities	-$64.00K	-$596.0K	-$290.0K
YoY Change	-75.67%	105.52%	-61.28%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$2.597M	$3.262M	-$1.659M
YoY Change	-62.82%	-296.62%	-408.94%
Cash From Investing Activities	$2.597M	$3.262M	-$1.659M
YoY Change	-62.82%	-296.62%	-12861.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-699.0K	-$1.457M	-$1.580M
YoY Change	2588.46%	-7.78%	21.35%
NET CHANGE
Cash From Operating Activities	-64.00K	-$596.0K	-$290.0K
Cash From Investing Activities	2.597M	$3.262M	-$1.659M
Cash From Financing Activities	-699.0K	-$1.457M	-$1.580M
Net Change In Cash	1.834M	$1.209M	-$3.529M
YoY Change	-72.61%	-134.26%	73.16%
FREE CASH FLOW
Cash From Operating Activities	-$64.00K	-$596.0K	-$290.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Revenues Revenues		usd
CY2024Q1	nssi	Cost Of Revenues CostOfRevenues		usd
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2024Q1	nssi	Vesting Of Restricted Stock Units VestingOfRestrictedStockUnits		usd
CY2023Q1	nssi	Vesting Of Restricted Stock Units VestingOfRestrictedStockUnits		usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
CY2024Q1	us-gaap	Interest Paid InterestPaid		usd
CY2023Q1	us-gaap	Interest Paid InterestPaid		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2024Q1	us-gaap	Revenues Revenues		usd
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	1-15288
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	NETWORK-1 TECHNOLOGIES, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-3027591
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	65 Locust Avenue
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Third Floor
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New Canaan
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06840
CY2024Q1	dei	City Area Code CityAreaCode	203
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	920-1055
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	NTIP
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23414473	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18105000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16896000	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	25289000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	28571000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	218000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	206000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	43612000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	45673000	usd
CY2024Q1	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1296000	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1326000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	4621000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5249000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16000	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	13000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	13000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	6005000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	6604000	usd
CY2024Q1	us-gaap	Assets Assets	49617000	usd
CY2023Q4	us-gaap	Assets Assets	52277000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	306000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	125000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	378000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	182000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	57000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	545000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	615000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1184000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1585000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23552561	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23552561	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	235000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	235000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	67560000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	67446000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19362000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16989000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	48433000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	50692000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49617000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52277000	usd
CY2023Q1	us-gaap	Revenues Revenues	537000	usd
CY2023Q1	nssi	Cost Of Revenues CostOfRevenues	151000	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	219000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	298000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	669000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	781000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	30000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	83000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	918000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1313000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-918000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-776000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	431000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	310000	usd
CY2024Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	48000	usd
CY2023Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	364000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	479000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	674000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-439000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-102000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-147000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-153000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-147000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-153000	usd
CY2024Q1	nssi	Loss Income Before Share Of Net Losses Of Equity Method Investee LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee	-292000	usd
CY2023Q1	nssi	Loss Income Before Share Of Net Losses Of Equity Method Investee LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee	51000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-628000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-674000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-920000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-623000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23540468	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23866821	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23540468	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23866821	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	50692000	usd
CY2024Q1	nssi	Dividends And Dividend Equivalents Declared DividendsAndDividendEquivalentsDeclared	-1207000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	115000	usd
CY2024Q1	nssi	Value Of Shares Delivered To Pay Withholding Taxes ValueOfSharesDeliveredToPayWithholdingTaxes	-61000	usd
CY2024Q1	nssi	Treasury Stock Purchased And Retired TreasuryStockPurchasedAndRetired	-186000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-920000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	48433000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	55109000	usd
CY2023Q1	nssi	Dividends And Dividend Equivalents Declared DividendsAndDividendEquivalentsDeclared	-1196000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	161000	usd
CY2023Q1	nssi	Value Of Shares Delivered To Pay Withholding Taxes ValueOfSharesDeliveredToPayWithholdingTaxes	-83000	usd
CY2023Q1	nssi	Treasury Stock Purchased And Retired TreasuryStockPurchasedAndRetired	-306000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-623000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	53062000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-920000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-623000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	30000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	83000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	115000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	161000	usd
CY2024Q1	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-628000	usd
CY2023Q1	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-674000	usd
CY2024Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-20000	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	270000	usd
CY2024Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-147000	usd
CY2023Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-153000	usd
CY2024Q1	nssi	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	16000	usd
CY2023Q1	nssi	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	16000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	12000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-229000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-13000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	181000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	94000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-17000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-17000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-490000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-471000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-596000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-290000	usd
CY2024Q1	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-5756000	usd
CY2023Q1	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-7671000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2494000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	9330000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3262000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1659000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1210000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1191000	usd
CY2024Q1	nssi	Value Of Shares Delivered To Fund Payment Of Withholding Taxes ValueOfSharesDeliveredToFundPaymentOfWithholdingTaxes	-61000	usd
CY2023Q1	nssi	Value Of Shares Delivered To Fund Payment Of Withholding Taxes ValueOfSharesDeliveredToFundPaymentOfWithholdingTaxes	-83000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	186000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	306000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1457000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1580000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1209000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3529000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16896000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13448000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18105000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9919000	usd
CY2024Q1	nssi	Accrued Dividend Rights On Restricted Stock Units AccruedDividendRightsOnRestrictedStockUnits	32000	usd
CY2023Q1	nssi	Accrued Dividend Rights On Restricted Stock Units AccruedDividendRightsOnRestrictedStockUnits	8000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	75000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80B_eus-gaap--NatureOfOperations_zxeMDQcd1eq9" style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE A – <span id="xdx_82F_z2DfrtdFex94">BASIS OF PRESENTATION AND NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[1] BASIS OF PRESENTATION</b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed consolidated financial statements are unaudited, but, in the opinion of the management of Network-1 Technologies, Inc. (the “Company”), contain all adjustments consisting only of normal recurring items which the Company considers necessary for the fair presentation of the Company’s financial position as of March 31, 2024, and the results of its operations, changes in stockholders’ equity, and its cash flows for the three month periods ended March 31, 2024 and March 31, 2023. The unaudited condensed consolidated financial statements included herein have been prepared in accordance with the accounting principles generally accepted in the United States of America (U.S. GAAP) for interim financial information and the instructions to Form 10-Q and Regulation S-X. Accordingly, certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP may have been omitted pursuant to such rules and regulations, although management believes that the disclosures are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 8, 2024. The results of operations for the three months ended March 31,2024 are not necessarily indicative of the results of operations to be expected for the full year.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Mirror Worlds Technologies, LLC and HFT Solutions, LLC. All intercompany balances and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[2] BUSINESS</b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is engaged in the development, licensing and protection of its intellectual property assets. The Company presently owns one-hundred two (<span id="xdx_901_eus-gaap--GainContingencyPatentsFoundInfringedUponNumber_uInteger_c20240101__20240331_zy0ZBnZ5pmQ9" title="U.S. Patents owned by the company">102</span>) U.S. patents, fifty-four (<span id="xdx_901_ecustom--ExpiredPatents_uInteger_c20240101__20240331_zmW1kwDocEf7" title="Expired patents">54</span>) of such patents have expired, and fifteen (<span id="xdx_908_ecustom--ForeignPatentsOwnedByCompany_uInteger_c20240101__20240331_zlPQHqruQfq9" title="Foreign patents owned by the company">15</span>) foreign patents related to (i) the Cox patent portfolio (the “Cox Patent Portfolio) relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (ii) the M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other things, enabling technology for authenticating and using eSIM (embedded Subscriber Identification Module) technology in Internet of Things (“IoT”), Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers, as well as automobiles; (iii) the HFT patent portfolio (the “HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds; (iv) the Mirror Worlds patent portfolio (the “Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) the remote power patent (the “Remote Power Patent”) covering delivery of Power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s current strategy includes continuing to pursue licensing opportunities for its patent portfolios. In addition, the Company reviews opportunities to acquire or license additional intellectual property as well as other strategic alternatives. The Company’s patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as the Company has achieved with respect to its Remote Power Patent and Mirror Worlds Patent Portfolio. In addition, the Company may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has also made equity investments totaling $<span id="xdx_901_eus-gaap--Investments_iI_pp0p0_c20240331__dei--LegalEntityAxis__custom--ILiADBiotechnologiesLLCMember_zhQfaTXo8BC2" title="Aggregate investment amount">7,000,000</span> in ILiAD Biotechnologies, LLC (“ILiAD”), a clinical stage biotechnology company (see Note J hereof).</span></p>
CY2024Q1	us-gaap	Gain Contingency Patents Found Infringed Upon Number GainContingencyPatentsFoundInfringedUponNumber	102	integer
CY2024Q1	nssi	Expired Patents ExpiredPatents	54	integer
CY2024Q1	nssi	Foreign Patents Owned By Company ForeignPatentsOwnedByCompany	15	integer
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zgfu6WeakQYe" style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 6pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span> </span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[1]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zKLDqsL5Hcl8">Use of Estimates and Assumptions</span></b></span></td></tr></table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s unaudited condensed consolidated financial statements include costs related to the Company’s assertion of litigation, valuation of the Company’s patent portfolios, stock-based compensation, the recoverability of deferred tax assets and the carrying value of the Company’s equity method investments. Actual results could be materially different from those estimates upon which the carrying values were based.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 12pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts recorded to reflect the Company’s share of income or losses of its equity method investee, accounted for under the equity method, are based on estimates and the unaudited results of operations of the equity method investee and may require adjustment in the future when the audit of the equity method investee is complete. The Company reports its share of the results of its equity method investee on a one quarter lag basis.</span></p>
CY2023Q1	us-gaap	Revenues Revenues	537000	usd
CY2023Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	537000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1319000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1319000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	615000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8473000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8473000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7177000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7147000	usd
CY2024Q1	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1296000	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1326000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	30000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	83000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	90000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	120000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	120000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	119000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	116000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	731000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1296000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	587500	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.81
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	70000	shares
CY2024Q1	nssi	Issuance Weightedaverage Grant Date Fair Value IssuanceWeightedaverageGrantDateFairValue	2.17
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	111250	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.45
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	546250	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.72
CY2024Q1	nssi	Dividend Equivalent Rights DividendEquivalentRights	35000	usd
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	546250	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	571250	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23540468	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23866821	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23540468	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23866821	shares
CY2024Q1	nssi	Restricted Stock Units Excluded From Computation Of Diluted Loss Per Share Because Effect Of Inclusion Would Have Been Antidilutive RestrictedStockUnitsExcludedFromComputationOfDilutedLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive	546250	shares
CY2023Q1	nssi	Restricted Stock Units Excluded From Computation Of Diluted Loss Per Share Because Effect Of Inclusion Would Have Been Antidilutive RestrictedStockUnitsExcludedFromComputationOfDilutedLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive	571250	shares
CY2024Q1	nssi	Contingency Fee Minimum ContingencyFeeMinimum	0.15	pure
CY2024Q1	nssi	Contingency Fee Maximum ContingencyFeeMaximum	0.24	pure
CY2024Q1	nssi	Legal Fees On Full Contingency Minimum LegalFeesOnFullContingencyMinimum	0.15	pure
CY2024Q1	nssi	Legal Fees On Full Contingency Maximum LegalFeesOnFullContingencyMaximum	0.30	pure
CY2024Q1	nssi	Legal Fees On Contingency Basis Minimum Remote Power Patent LegalFeesOnContingencyBasisMinimumRemotePowerPatent	0.15	pure
CY2024Q1	nssi	Legal Fees On Contingency Basis Maximum Remote Power Patent LegalFeesOnContingencyBasisMaximumRemotePowerPatent	0.40	pure
CY2022Q1	nssi	Hft Patent Acqusition Cash At Closing HftPatentAcqusitionCashAtClosing	500000	usd
CY2022Q1	nssi	Contingent Common Stock Issued Upon Achieving Certain Milestones ContingentCommonStockIssuedUponAchievingCertainMilestones	375000	usd
CY2022Q1	nssi	First50 Million First50Million	0.15	pure
CY2022Q1	nssi	Greater Than50 Million GreaterThan50Million	0.175	pure
CY2024Q1	nssi	Obligated To Pay Seller Net Proceed Percentage ObligatedToPaySellerNetProceedPercentage	0.125	pure
CY2024Q1	nssi	First125 Million First125Million	0.10	pure
CY2024Q1	nssi	Next125 Million Next125Million	0.15	pure
CY2024Q1	nssi	Over250 Million Over250Million	0.20	pure
	nssi	Recognition Net Proceeds Payment Related To Mirror Worlds Patents RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents	3127000	usd
CY2024Q1	nssi	First100 First100	0.14	pure
CY2024Q1	nssi	Next100 Next100	0.05	pure
CY2024Q1	nssi	Aadditional Consideration AadditionalConsideration	250000	usd
CY2024Q1	nssi	Base Rent BaseRent	5500	usd
CY2022Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.042	pure
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	57000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	81000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	23000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	17000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	19000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	17000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	19000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	59000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	26000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	85000	usd
CY2024Q1	nssi	Operating Leases Imputed Interest OperatingLeasesImputedInterest	-4000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	81000	usd
CY2022Q1	nssi	Ceo Incentive Compensation Of License Revenue Remote Power Patent CeoIncentiveCompensationOfLicenseRevenueRemotePowerPatent	0.10	pure
CY2024Q1	us-gaap	Salaries And Wages SalariesAndWages	0	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	27000	usd
CY2022Q1	nssi	Ceo Incentive Compensation Of License Revenue Remote Power Patent1 CeoIncentiveCompensationOfLicenseRevenueRemotePowerPatent1	0.05	pure
CY2024Q1	nssi	Conditional Settlement Payment Unrecognized ConditionalSettlementPaymentUnrecognized	150000	usd
CY2023Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10091000	usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3466000	usd
CY2023Q4	nssi	Comprehensive Loss ComprehensiveLoss	-9470000	usd
CY2022Q4	nssi	Comprehensive Loss ComprehensiveLoss	-9911000	usd
CY2023Q2	nssi	Stock Repurchase Program Dollar Amount That May Be Repurchased StockRepurchaseProgramDollarAmountThatMayBeRepurchased	5000000	usd
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	9724540	shares
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	18894986	usd
	nssi	Weighted Average Price Per Share Common Stock Subject To Repurchase WeightedAveragePricePerShareCommonStockSubjectToRepurchase	1.97
CY2024Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	83744	shares
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	182070	usd
CY2024Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	2.17
CY2022Q3	nssi	Excise Tax Description ExciseTaxDescription	The excise tax applies in cases where the total value of the stock repurchase during the taxable year exceeds $1,000,000
CY2024Q1	nssi	Value Of Remaining Shares That May Be Repurchased ValueOfRemainingSharesThatMayBeRepurchased	4190635	usd
CY2024Q1	nssi	Fdic Insured Amount FdicInsuredAmount	250000	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	1153000	usd
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	18040000	usd
CY2024Q1	nssi	Dividends Per Share DividendsPerShare	0.05
CY2024Q1	nssi	Dividends Per Share Annual DividendsPerShareAnnual	0.10
CY2024Q1	us-gaap	Dividends Cash DividendsCash	1175000	usd

Files In Submission

Name	View Source	Status
0001072613-24-000458-index-headers.html	Edgar Link	pending
0001072613-24-000458-index.html	Edgar Link	pending
0001072613-24-000458.txt	Edgar Link	pending
0001072613-24-000458-xbrl.zip	Edgar Link	pending
exh31-1_18832.htm	Edgar Link	pending
exh31-2_18832.htm	Edgar Link	pending
exh32-1_18832.htm	Edgar Link	pending
exh32-2_18832.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
network1_10q-033124.htm	Edgar Link	pending
nssi-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
nssi-20240331_cal.xml	Edgar Link	unprocessable
nssi-20240331_def.xml	Edgar Link	unprocessable
network1_10q-033124_htm.xml	Edgar Link	completed
nssi-20240331_lab.xml	Edgar Link	unprocessable
nssi-20240331_pre.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

2024 Q2 Form 10-Q Financial Statement

#000107261324000458 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIP NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

2024 Q2 Form 10-Q Financial Statement

#000107261324000458 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip